To evaluate the impact of FOXO1 on B-ALL relapse, we examined the FOXO1 mRNA levels in diagnostic and relapsed B-ALL samples from our single institution using RT-qPCR assay. This evidence concerns the gene FOXO1 and acute lymphoblastic leukemia.